Does Dr. SIJUWADE ADEGOJU have financial conflicts of interest?

Dr. SIJUWADE ADEGOJU (MD) has received a total of $676 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $676 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SIJUWADE ADEGOJU?

According to CMS Open Payments data, Dr. SIJUWADE ADEGOJU received funding from JANSSEN PHARMACEUTICALS ($222), AXSOME THERAPEUTICS ($138), and TEVA PHARMACEUTICALS USA ($122).

Does Dr. SIJUWADE ADEGOJU receive research grants or speaking fees?

Dr. SIJUWADE ADEGOJU has received $676 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SIJUWADE ADEGOJU

MDReal-Time Hydrated

Specialty: Nurse Practitioner, Psych/Mental Health

Practice Location: RICHMOND, TX 77406

NPI Number: 1538752837

LIFETIME INDUSTRY VALUE

$676

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ADEGOJU is a verified Nurse Practitioner, Psych/Mental Health practitioner based in RICHMOND, TX.

Between 2021 and 2025, Dr. ADEGOJU had an overall industry promotional and research financial footprint of $676 as recorded in the federal CMS Open Payments database.

$676 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ADEGOJU's primary funding source is JANSSEN PHARMACEUTICALS, which accounts for $222 (representing 32.8% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

JANSSEN PHARMACEUTICALS

Rank 1

$222

32.8%

AXSOME THERAPEUTICS

Rank 2

$138

20.4%

TEVA PHARMACEUTICALS USA

Rank 3

$122

18%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.